Leuven Pharma Services
0643.870.855 · rovalta.com · 24/09/2026
Leuven Pharma Services
Overview
What does Leuven Pharma Services do?
Leuven Pharma Services is a Private limited company incorporated in 2015. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Leuven. It employs on average 2,3 ETP workers (FTE).
3018 Leuven · FlandreSee on map
Joint committees (1)
- 313
Trend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||
| Gross margin | 190,6 k € | -28.9% | 268,2 k € | -20.2% | 336,2 k € | -7.4% | 363,3 k € | +43.7% | 252,8 k € | +26.0% | 200,7 k € | -11.9% | 227,8 k € | -26.8% | 311,4 k € | +16.8% | 266,6 k € | +88.3% | 141,6 k € |
| EBITDA | 10,9 k € | -90.0% | 108,9 k € | -38.5% | 176,9 k € | +7.7% | 164,2 k € | +108% | 78,8 k € | +256% | 22,2 k € | -79.8% | 109,8 k € | -46.6% | 205,6 k € | +40.2% | 146,6 k € | +150% | 58,7 k € |
| Operating result | 7,3 k € | -93.0% | 104,3 k € | -38.7% | 170,2 k € | +8.0% | 157,5 k € | +106% | 76,4 k € | +248% | 22 k € | -80.0% | 109,6 k € | -46.7% | 205,6 k € | +40.2% | 146,6 k € | +150% | 58,7 k € |
| Net result | -32,8 k € | -151% | 64,2 k € | -45.8% | 118,5 k € | +9.3% | 108,5 k € | +135% | 46,1 k € | +4096% | 1,1 k € | -98.4% | 69,5 k € | -49.6% | 137,8 k € | +64.9% | 83,6 k € | +242% | 24,4 k € |
| Balance sheet | |||||||||||||||||||
| Equity | 339,6 k € | -49.5% | 672,3 k € | +10.6% | 608,1 k € | +24.2% | 489,6 k € | +28.5% | 381,1 k € | +13.8% | 335 k € | +0.3% | 333,9 k € | +26.3% | 264,4 k € | +109% | 126,6 k € | +194% | 43 k € |
| Total assets | 2,1 M € | +1.9% | 2,1 M € | +1.2% | 2,1 M € | +3.3% | 2 M € | +2.3% | 1,9 M € | +0.6% | 1,9 M € | -1.2% | 2 M € | +1.1% | 1,9 M € | +0.9% | 1,9 M € | -1.2% | 1,9 M € |
| Cash | 16,6 k € | -37.8% | 26,7 k € | +95.3% | 13,7 k € | +114% | 6,4 k € | -81.4% | 34,2 k € | -9.6% | 37,8 k € | +370% | 8 k € | -84.3% | 51,2 k € | +53.3% | 33,4 k € | -47.5% | 63,7 k € |
| Debts | 1,7 M € | +24.6% | 1,4 M € | -2.8% | 1,4 M € | -3.6% | 1,5 M € | -4.0% | 1,6 M € | -2.2% | 1,6 M € | -1.5% | 1,6 M € | -2.9% | 1,7 M € | -6.8% | 1,8 M € | -5.7% | 1,9 M € |
| Other | |||||||||||||||||||
| Workforce | 2,3 ETP | 0.0% | 2,3 ETP | 0.0% | 2,3 ETP | -28.1% | 3,2 ETP | -3.0% | 3,3 ETP | +3.1% | 3,2 ETP | +39.1% | 2,3 ETP | +15.0% | 2,0 ETP | 0.0% | 2,0 ETP | +11.1% | 1,8 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 5 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Apotheek Wijgmaal Brug● Active | 0457.651.542 |
Apotheek Wijgmaal Dorp● Active | 0449.259.854 |
Beheer Van Den Borre● Active | 0477.372.533 |
Pardimmo● Active | 0400.644.642 |
| 0824.219.193 | |
Wipoli● Active | 0738.938.377 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2026 | 31/08/2025 | 26/08/2024 | 27/07/2023 | 29/07/2022 | 26/08/2021 |
| General meeting | 02/06/2026 | 03/06/2025 | 04/06/2024 | 06/06/2023 | 07/06/2022 | 01/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
10 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 02/06/2026 | 29/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 03/06/2025 | 31/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 04/06/2024 | 26/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 06/06/2023 | 27/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 07/06/2022 | 29/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 01/06/2021 | 26/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 02/06/2020 | 30/08/2020 | Dutch | |
| Abridged model | 31/12/2018 | 04/06/2019 | 06/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 12/06/2018 | 17/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 07/06/2017 | 26/07/2017 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 5 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-32,8 k €↓
- 2024Annual accounts 202464,2 k €↓
- 2023Annual accounts 2023118,5 k €↑
- 2022Annual accounts 2022108,5 k €↑
- 2021Annual accounts 202146,1 k €↑
- 2020Annual accounts 20201,1 k €↓
- 2019Annual accounts 201969,5 k €↓
- 2018Annual accounts 2018137,8 k €↑
- 2017Annual accounts 201783,6 k €↑
- 2016Annual accounts 201624,4 k €
- 04/12/2015IncorporationPrivate limited company